Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Dryburgh

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pathology|December 1, 1995
Audit of an emergency biochemistry serviceW S Smellie, M J Murphy, P J Galloway, et al.
Clinical Science (London, England : 1979)|February 1, 1984
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calciumS H Ralston, I Fogelman, M D Gardner, et al.
Lancet (London, England)|March 24, 1990
Use of bisphosphonates in hypercalcaemia due to malignancyS H Ralston, S J Gallacher, U Patel, et al.
Lancet (London, England)|April 13, 1985
Hypercalcaemia of malignancyS H Ralston, F J Dryburgh, R A Cowan, et al.
Lancet (London, England)|October 26, 1985
Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemiaS H Ralston, M D Gardner, F J Dryburgh, et al.
The Quarterly Journal of Medicine|March 1, 1986
Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumourS H Ralston, B F Boyce, R A Cowan, et al.
Lancet (London, England)|November 18, 1989
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemiaS H Ralston, S J Gallacher, U Patel, et al.
Postgraduate Medical Journal|November 1, 1990
Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronateS J Gallacher, S H Ralston, F J Dryburgh, et al.
Calcified Tissue International|December 1, 1992
Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancyS J Gallacher, W D Fraser, F C Logue, et al.
Bone and Mineral|December 1, 1991
A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemiaS J Gallacher, S H Ralston, W D Fraser, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pathology|December 1, 1995
Audit of an emergency biochemistry serviceW S Smellie, M J Murphy, P J Galloway, et al.
Clinical Science (London, England : 1979)|February 1, 1984
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calciumS H Ralston, I Fogelman, M D Gardner, et al.
Lancet (London, England)|March 24, 1990
Use of bisphosphonates in hypercalcaemia due to malignancyS H Ralston, S J Gallacher, U Patel, et al.
Lancet (London, England)|April 13, 1985
Hypercalcaemia of malignancyS H Ralston, F J Dryburgh, R A Cowan, et al.
Lancet (London, England)|October 26, 1985
Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemiaS H Ralston, M D Gardner, F J Dryburgh, et al.
The Quarterly Journal of Medicine|March 1, 1986
Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumourS H Ralston, B F Boyce, R A Cowan, et al.
Lancet (London, England)|November 18, 1989
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemiaS H Ralston, S J Gallacher, U Patel, et al.
Postgraduate Medical Journal|November 1, 1990
Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronateS J Gallacher, S H Ralston, F J Dryburgh, et al.
Calcified Tissue International|December 1, 1992
Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancyS J Gallacher, W D Fraser, F C Logue, et al.
Bone and Mineral|December 1, 1991
A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemiaS J Gallacher, S H Ralston, W D Fraser, et al.
Pageof 4